• Ework Group: Ework Group - Weaker market takes its toll (ABG Sundal Collier)
    2024-05-02 10:30
  • Elanders: ANALYS Elanders: Låg efterfrågan från konsumenter i Q1 (Analysguiden)
    2024-05-02 10:15
  • New Wave Group: ANALYS New Wave Group: Tuff start på året – men bättre framöver (Analysguiden)
    2024-05-02 10:15
  • KH Group: Turnaround setback (Inderes)
    2024-05-02 10:14
  • Ework Group: Eworks rapport något under förväntningarna (Pinpoint Estimates)
    2024-05-02 10:09
  • Devyser Diagnostics: Devyser: Redeye Q1 preview (Redeye)
    2024-05-02 09:56
  • AcuCort: Aktieanalys på AcuCort - Inleder kommersialisering inom Norden (Analyst Group)
    2024-05-02 09:56
  • Enrad: Analysuppdatering Enrad: Bra start på 2024 trots svag marknad i Sverige (Carlsquare)
    2024-05-02 09:40
  • Enrad: Research Update Enrad Q1 2024: Better than expected start to 2024 (Carlsquare)
    2024-05-02 09:40
  • Cardeon: Aktieanalys på Cardeon - Kurspress bjuder in till attraktiv Risk-Reward (Analyst Group)
    2024-05-02 09:24
  • BankNordik: Flash Comment: 2024 starts with a mixed bag (Nordea)
    2024-05-02 09:10
  • Embracer Group: Embracer Group: Here is what investors are asking (Redeye)
    2024-05-02 09:05
  • Artificial Solutions International: Artificial Solutions: Intervju med vd Per Ottosson (Redeye)
    2024-05-02 09:00
  • Bonesupport: Bonesupport: Here is what investors are asking (Redeye)
    2024-05-02 09:00
  • Evolution: Evolution: Here is what investors are asking (Redeye)
    2024-05-02 09:00
  • AlzeCure Pharma: AlzeCure Pharma: Here is what investors are asking (Redeye)
    2024-05-02 09:00
  • Sdiptech: Sdiptech: Here is what investors are asking (Redeye)
    2024-05-02 09:00
  • SSH Communications Security: SSH Communications: Here is what investors are asking (Redeye)
    2024-05-02 09:00
  • TagMaster: TagMaster: Here is what investors are asking (Redeye)
    2024-05-02 09:00
  • BioInvent International: BioInvent: Here is what investors are asking (Redeye)
    2024-05-02 09:00
  • CellaVision: CellaVision: Here is what investors are asking (Redeye)
    2024-05-02 09:00
  • Humble Group: Humble Group - Q1: Solid gross margin, miss on EBITA (ABG Sundal Collier)
    2024-05-02 09:00
  • Sedana Medical: Sedana Medical: Here is what investors are asking (Redeye)
    2024-05-02 09:00
  • Tobii Dynavox: Tobii Dynavox: Here is what investors are asking (Redeye)
    2024-05-02 09:00
  • Taaleri: Taaleri Q1 on Tuesday: Eyes on the ramp-up of private equity funds (Inderes)
    2024-05-02 08:33
  • Boreo: Boreo: Uncertainties around - SEB (SEB Research)
    2024-05-02 08:31
  • Lindex Group: Finnish trade continued to grow in March, driven by food products (Inderes)
    2024-05-02 08:14
  • Raketech: Raketech: Soft Q1-results and lowered guidance (Redeye)
    2024-05-02 08:11
  • Medivir: Medivir - Uppdaterade detaljer om studiedesignen i Q1-rapport (Penser Access)
    2024-05-02 08:00
  • MTI Investment: Analyst Group kommenterar MTI Investments nya aktieägarlån till AML Finance Limited (Analyst Group)
    2024-05-02 08:00
  • Puuilo: Puuilo announced a new store opening (Inderes)
    2024-05-02 07:53
  • Viva Wine: Preview Viva Wine Group, Q1 2024: Solid growth but at modest margins (Carlsquare)
    2024-05-02 07:47
  • Nexstim: Licensing period for Nexstim's technology starting? (Inderes)
    2024-05-02 07:40
  • Freemelt Holding: Freemelt: Extending the UKAEA project (Redeye)
    2024-05-02 07:25
  • Annexin Pharmaceuticals: Annexin Pharmaceuticals: Intervju med vd Anders Haegerstrand och CSO/CMO Anna Frostegård (Redeye)
    2024-05-02 07:15
  • DistIT: DistIT Group: Macro headwinds, profitability first - SEB (SEB Research)
    2024-05-02 07:09
  • Successful expansion of the ferry contract (Nordea)
    2024-05-02 07:02
  • Rottneros: Rottneros - A shaky start to the year (ABG Sundal Collier)
    2024-05-02 07:00
  • Boozt: Boozt - Recording of Q1 2024 result presentation (HC Andersen Capital via Inderes)
    2024-05-01 20:11
  • Green Hydrogen Systems: Green Hydrogen Systems (One-pager): Q1 2024 trading statement confirms guidance (HC Andersen Capital via Inderes)
    2024-05-01 16:30